Patient eligibility criteria and randomization
allergic, malignancy, pitting oedema, Rupture, acute ATR, rupture, thrombophlebitis, heart failure
THROMBOPHLEBITIS, HEART FAILURE, RENAL FAILURE, COAGULATION DISORDER
The database included patients diagnosed with acute ATR and surgically repaired at the Karolinska University Hospital. A total of 55 patients were randomly selected from 2 previously conducted randomized control trials (RCT) and were dichotomized into two clinical cohorts according to their outcome based on Achilles Tendon Rupture Score (ATRS) (Basic information and characteristics of all the participants.The clinical and functional characteristics of ATR patients included in the study. BMI, body mass index; ATRS, Achilles tendon Total Rupture Score (0-100, worst = 0); HRT, Heal Rise Test (0-100, worst = 0 for each category); QOL, Quality of Life; LSI, Limb Symmetry Index). Data presented as median with lower and upper interquartile ranges. Comparison between good versus poor outcome was measured by Mann-Whitney U test. A p value < 0.05 was set for statistical significance between group. n, no significance.Exclusion criteria used in the RCTs included inability to provide verbal and/or written consent for participating in the study, current anticoagulation treatment, allergic to contrast liquid, known renal failure, heart failure with pitting oedema, thrombophlebitis or known coagulation disorder, inability to follow instructions or were planned for follow up at other hospitals, received other surgery during the month before tendon rupture, and patients with known malignancy, haemophillia or pregnancy.